Suites Investment

2 mins 04/08/21
Author name: met_ra_ric

Metrics Contract Services Unveils New Commercial Production Suites and Equipment

July 29, 2021 Greenville, N.C. – Metrics Contract Services (Metrics), a full-service global contract development and manufacturing organization (CDMO), has expanded its novel oral solid dose commercial facility in Greenville, North Carolina, adding 3,760 square feet of production space and new equipment.

The expansion completes a further $10 million investment following the completion of an $80 million project in 2018, and consists of three new manufacturing suites including a:

  • Combination dispensing/flex room
  • Flex room
  • Dedicated suite to house a newly commissioned Fette FE55 contained tablet press with bilayer capability.

All three suites feature: separate personnel and equipment airlocks for compliant one-way flow to prevent contamination; stainless steel doors and finishes; robust epoxy paint and floor finishes; low wall HEPA filter exhausts with bag in – bag out design; and fogging showers. The additions accommodate the company’s growing portfolio of commercial services following sustained increase in demand from clients for high potent handling capabilities.

“The new commercial production suites will accommodate our customers’ demand for increased flexibility and capacity. This trio of rooms will enable us to further tailor equipment trains to the applicable process, particularly those that require smaller batch sizes,” said John Ross, President of Mayne Pharma U.S and Metrics Contract Services. “Our clients will see immediate benefits through greater flexibility and improved potent handling.”

The expansion project began in Q3 2020 and is indicative of the company’s ongoing commitment to expanding its novel oral solid dose manufacturing capabilities to provide clients with quality services from initial concept through to global commercialization. Metrics is looking ahead at the next phase of investment with the addition of further potent handling expansion and potential adjacent formulation technologies.


Other News & Events